|
EXHIBIT 10.7
EMPLOYMENT AGREEMENT
BY AND BETWEEN
JAZZ PHARMACEUTICALS, INC.
AND
JANNE L.T. WISSEL
TABLE OF
CONTENTS
| |
|
|
|
|
|
|
|
|
|
Page
|
|
1.
|
|
Integration.
|
|
1
|
|
|
|
|
2.
|
|
Definitions.
|
|
2
|
|
|
|
|
3.
|
|
Employment.
|
|
8
|
|
|
|
|
4.
|
|
Compensation of the Executive.
|
|
9
|
|
|
|
|
5.
|
|
Termination.
|
|
10
|
|
|
|
|
6.
|
|
Compensation Upon Termination.
|
|
11
|
|
|
|
|
7.
|
|
Restrictions on Transfer.
|
|
13
|
|
|
|
|
8.
|
|
Repurchase of Unvested Shares.
|
|
13
|
|
|
|
|
9.
|
|
Put/Call Rights on Vested Shares.
|
|
15
|
|
|
|
|
10.
|
|
Permitted Transfers; Prohibited
Transfers.
|
|
15
|
|
|
|
|
11.
|
|
Legend; Stop Transfer Instructions.
|
|
16
|
|
|
|
|
12.
|
|
Survival of Certain Sections.
|
|
17
|
|
|
|
|
13.
|
|
Ownership.
|
|
17
|
|
|
|
|
14.
|
|
Market Standoff.
|
|
17
|
|
|
|
|
15.
|
|
Escrow of Shares.
|
|
18
|
|
|
|
|
16.
|
|
Assignment and Binding Effect.
|
|
18
|
|
|
|
|
17.
|
|
Notices.
|
|
18
|
|
|
|
|
18.
|
|
Governing Law.
|
|
18
|
|
|
|
|
19.
|
|
Amendment and Waiver.
|
|
18
|
|
|
|
|
20.
|
|
Severability.
|
|
19
|
|
|
|
|
21.
|
|
Interpretation; Construction.
|
|
19
|
|
|
|
|
22.
|
|
Attorneys’ Fees.
|
|
19
|
i
| |
|
|
|
|
|
|
|
|
23.
|
|
Cumulative Remedies.
|
|
19
|
|
|
|
|
24.
|
|
Further Assurances.
|
|
19
|
|
|
|
|
25.
|
|
Counterparts.
|
|
19
|
ii
EMPLOYMENT
AGREEMENT
This EMPLOYMENT AGREEMENT (the " Agreement ") is
made and entered into on February 18, 2004, by and between
JAZZ PHARMACEUTICALS, INC., a Delaware corporation (the "
Company "), and JANNE L.T. WISSEL (the "
Executive "). The Company and the Executive are
hereinafter collectively referred to as the " Parties
", and individually referred to as a " Party ".
RECITALS
A. The Company retained the services of the Executive pursuant
to an offer letter, dated May 29, 2003 (the " Offer
Letter ").
B. The Executive and the Company entered into an Option Exercise
and Stock Purchase Agreement, dated October 14, 2003 (the "
Stock Agreement ").
C. Certain parties are now proposing to purchase shares of the
Company’s Series B Preferred Stock and Series B Prime
Preferred Stock.
D. The Company and the Executive wish to enter into this
Agreement in order to (i) amend and restate the terms and
conditions of the Company’s retention of the
Executive’s services and (ii) amend and restate the
terms and conditions of certain restrictions on the capital stock
of the Company held by the Executive.
AGREEMENT
NOW THEREFORE, FOR GOOD AND VALUABLE CONSIDERATION, THE PARTIES
AGREE AS FOLLOWS:
This Agreement and the Transactional Agreements
constitute the entire agreement between the Company and the
Executive regarding the subject matter hereof and thereof and
supersede and replace any and all prior oral and written
negotiations, correspondence, understandings and agreements between
the parties regarding the subject matter hereof and thereof;
provided, however, the Offer Letter, the Stock Agreement, and the
Employee Confidential Information and Inventions Agreement between
the Company and the Executive shall remain in full force and
effect. To the extent this Agreement conflicts with the Offer
Letter or the Stock Agreement, this Agreement controls. To the
extent this Agreement conflicts with the Employee Confidential
Information and Inventions Agreement, the Employee Confidential
Information and Inventions Agreement controls. To the extent this
Agreement conflicts with the terms of the Company’s employee
handbook in effect from time to time, this Agreement controls. For
purposes of this Agreement, the " Transactional
Agreements " shall mean the Preferred Stock Purchase
Agreement (the " Purchase Agreement ") dated
January 27,
2004 among the Company and other parties
identified therein, the Amended and Restated Investor Rights
Agreement (the " Investor Rights Agreement ") of even
date herewith among the Company and other parties identified
therein, the Amended and Restated Right of First Refusal and
Co-Sale Agreement (the " Right of First Refusal
Agreement ") of even date herewith among the Company and
the parties identified therein, and the Amended and Restated Voting
Agreement (the " Voting Agreement ") of even date
herewith among the Company and the parties identified therein, each
as may be amended in accordance with its terms.
For purposes of this Agreement, the following
terms shall have the following meanings:
2.1. " Affiliate " shall mean, with respect to any
Person, a Person directly or indirectly controlling, controlled by,
or under common control with, such Person.
2.2. " Annual Bonus Rate for the Termination Year
" shall mean:
2.2.1. if the Executive has not previously received an annual
bonus at the time of termination, the Executive’s Bonus Rate;
and
2.2.2. if the Executive has previously received an annual bonus
payment at the time of termination, the lesser of the
Executive’s Bonus Rate and the product of the Managers’
Bonus Rate for the year in which the termination occurs times the
Executive’s target bonus percentage for the year in which the
termination occurs.
2.3. " Annual Bonus Rate for the Reference Year "
shall mean:
2.3.1. if the Executive has not previously received an annual
bonus at the time of termination, the Executive’s Bonus Rate;
and
2.3.2. if the Executive has previously received an annual bonus
payment at the time of termination, the lesser of the
Executive’s Bonus Rate and the product of the Managers’
Bonus Rate for the Reference Year times the Executive’s
target bonus percentage for the year in which the termination
occurs.
2.4. " Call " shall mean the right of the Company
to buy Vested Shares pursuant to Section 9.4.
2.5. " Cause " shall mean the occurrence of any of
the following events:
2.5.1. the Executive’s willful misconduct or gross
negligence that is materially injurious to the Company;
2
2.5.2. the Executive’s conviction or plea
of guilty or nolo contendere to any felony or crime involving moral
turpitude;
2.5.3. the Executive’s commission of any act of fraud with
respect to the Company;
2.5.4. the Executive’s willful violation of any federal or
state securities law; or
2.5.5. the Executive’s willful and continued failure to
perform the Executive’s job duties after 30 days’
written notice from the Board setting forth in detail the specific
respects in which it believes the Executive has willfully and not
substantially performed such job duties and a failure by Executive
to cure within such 30-day period if capable of being cured.
2.6. " Change of Control " means (i) a sale
of all or substantially all of the assets of the Company to a
Person that is neither an Initial B/P Holder nor an Affiliate of an
Initial B/P Holder, or to a Group that does not include an Initial
B/P Holder or an Affiliate of an Initial B/P Holder, or a sale of
all or substantially all of the assets of the Company to a Person
in which the stockholders of the Company immediately prior to such
transaction do not control more than 50% of the voting power
immediately following the transaction; (ii) a transaction or
series of related transactions by the Company (other than
transaction(s) determined by the Board of Directors to be primarily
for cash financing purposes) or by any stockholder or stockholders
of the Company resulting in more than 50% of the voting power of
the Company being held by a Person that is neither an Initial B/P
Holder nor an Affiliate of an Initial B/P Holder, or by a Group
that does not include an Initial B/P Holder or an Affiliate of an
Initial B/P Holder; (iii) a merger or consolidation of the
Company with or into a Person that is neither an Initial B/P Holder
nor an Affiliate of an Initial B/P Holder, or with or into a Group
that does not include an Initial B/P Holder or an Affiliate of an
Initial B/P Holder, if and only if, after such merger or
consolidation, directors of the Company immediately prior to such
merger or consolidation do not constitute a majority of the
directors of the surviving entity or its parent.
2.7. " Change of Control Severance " shall
mean:
2.7.1. an amount, payable in one lump sum at the time of
termination, equal to the product of (a) one-twelfth of the
Executive’s annual base salary in effect at the time of
termination times (b) the number of months included in the
Severance Period, subject to standard deductions and
withholdings;
2.7.2. an amount, payable in one lump sum at the time of
termination, equal to the product of the Executive’s Bonus
Rate times the Executive’s base salary in effect at the time
of termination prorated, on the basis of a 365-day year, to reflect
the number of days elapsed in the year of Executive’s
termination prior to and including the date of termination;
3
2.7.3. an amount, payable in one lump sum at the
time of termination, equal to the product of (a) one-twelfth
of the Executive’s annual base salary as in effect at the
time of termination times (b) the Executive’s Bonus Rate
times (c) the number of months included in the Severance
Period, subject to standard deductions and withholdings;
and
2.7.4. an amount, payable monthly, equal to the monthly COBRA
payments to continue medical and dental benefits for a period
ending on the earlier of (a) the end of the last month of the
Severance Period and (b) the date on which the Executive is
covered by medical and dental insurance through his or her own
employment.
2.8. " Common Shares " shall mean the shares of
Common Stock that the Executive now owns or hereafter acquires from
the Company.
2.9. " Complete Disability " shall mean the
inability of the Executive to perform the Executive’s duties
under this Agreement because the Executive has become permanently
disabled within the meaning of any policy of disability income
insurance then in force covering employees of the Company. In the
event the Company has no policy of disability income insurance in
force covering employees of the Company, the term " Complete
Disability " shall mean the inability of the Executive to
perform the Executive’s duties under this Agreement by reason
of any incapacity, physical or mental, which the Board, based upon
medical advice or an opinion provided by a licensed physician
acceptable to the Board and the Executive, determines to have
incapacitated the Executive from performing all of the
Executive’s usual services for the Company for a period of at
least 120 days during any 12 month period (whether or not
consecutive) and is expected to continue to incapacitate the
Executive thereafter. Based upon such medical advice or opinion,
the determination of the Board shall be final and binding and the
date such determination is made shall be the date of such Complete
Disability for purposes of this Agreement.
2.10. " Executive’s Bonus Rate " shall
mean:
2.10.1. if the Executive has not previously received an annual
bonus, the target bonus percentage for the year in which the
termination occurs;
2.10.2. if the Executive has previously received one annual
bonus payment at the time of termination, that percentage
calculated by dividing the annual bonus actually paid for the year
to which the bonus relates by the salary actually paid for such
year; or
4
2.10.3. if the Executive has received more than
one annual bonus payment at the time of termination, the average
over the prior two years of the percentage calculated by dividing
the bonus actually paid for the year to which the bonus relates by
the salary actually paid for such year.
2.11. " Fair Market Value " shall mean the value
of the Shares determined in good faith by the Board of Directors,
provided that (a)(i) if the Shares are listed on any
established stock exchange or a national market system, their fair
market value shall be the average of the closing sales price for
the Shares as quoted on such system or exchange (or the largest
such exchange) over the 5-trading-day period ending immediately
prior to the date of the Notice of Put/Call Exercise, as reported
in the Wall Street Journal or similar publication, and (ii) if
the Shares are regularly quoted by a recognized securities dealer
but selling prices are not reported, their fair market value shall
be the mean between the closing bid and asked prices for the Shares
on the date of the Notice of Put/Call Exercise (or if there are no
quoted prices for such date, then for the last preceding business
day on which there were quoted prices), and (b) if clauses
(a)(i) or (a)(ii) are not applicable, the Board of Directors shall
apply valuation techniques generally used by reputable investment
bankers (without giving effect to any premium that might be paid by
a strategic buyer in an acquisition) to determine the value of the
Shares as of the date of the Notice of Put/Call Exercise.
2.12. " Founder Shares " shall mean shares of
Common Stock that the Executive owns immediately prior to the
Initial Closing (as defined in the Purchase Agreement).
2.13. " Good Reason " shall mean the occurrence of
any of the following events without the Executive’s written
consent:
2.13.1. a substantial diminution by the Company in the nature or
status of the Employee’s responsibilities or an adverse
change in title or reporting level as they exist on the date of
this Agreement, or the addition of responsibilities of a nature or
status inconsistent with the office of Senior Vice President,
Development of a company such as the Company;
2.13.2. the relocation of the Company’s executive offices
or principal business location to a point more than 20 miles (or
greater distance with the prior written consent of the Executive)
from the Company’s current facilities in Palo Alto,
California;
2.13.3. a reduction by the Company of the Executive’s base
salary or bonus rate as initially set forth herein or as the same
may be increased from time to time, other than a comparable
across-the-board reduction in base salary or bonus rate of
(a) the Company’s employees generally, or (b) the
senior officers generally (if approved by a majority of the
Company’s senior officers), in each case as a result of the
Company’s need to conserve capital;
5
2.13.4. any action by the Company (including the
elimination of benefit plans without providing substitutes thereof
or the reduction of the Executive’s benefits thereunder) that
would materially diminish the aggregate value of the
Executive’s fringe benefits as they exist at such time, other
than a comparable across-the-board diminution in fringe benefits of
(a) the Company’s employees generally, or (b) the
senior officers generally (if approved by a majority of the
Company’s senior officers), in each case as a result of the
Company’s need to conserve capital; or
2.13.5. a material breach of this Agreement by the Company.
2.14. " Group " means two or more Persons acting
together as a partnership, limited partnership, syndicate or other
group for the purpose of acquiring, holding or disposing of or
voting securities of the Company.
2.15. " Initial B/P Holder " means a Person that
holds any shares of Series B/P Preferred as of the date the first
share of Series B/P Preferred is issued.
2.16. " Manager " shall mean any of Samuel R.
Saks, Bruce C. Cozadd, Robert M. Myers, Matthew K. Fust, Carol A.
Gamble and Janne L. T. Wissel.
2.17. " Managers’ Bonus Rate " shall mean
the average for all Managers of X/Y where X is the actual bonus
paid for the year in which a termination occurs or the Reference
Year, as appropriate, and Y is the target bonus for such year; but
including only those Managers who were employed for the entire
year; provided that if there were no Managers employed for the
entire year, then the Managers’ Bonus Rate shall equal the
Executive’s Bonus Rate.
2.18. " Management Team " shall mean the Chairman
of the Board (if the Chairman is an officer of the Company), the
Chief Executive Officer, and the management employees reporting
directly to the Chairman or the Chief Executive Officer, in office
immediately prior to a Significant Transaction.
2.19. " Original Purchase Price " for each Share
shall mean the price paid by the Executive for that Share (as
appropriately adjusted for any stock combination, stock split,
stock dividend, recapitalization or other similar transaction after
the date hereof).
2.20. " Person " means an individual, partnership,
corporation, business trust, joint stock company, trust,
unincorporated association, joint venture, governmental authority
or other entity of whatever nature, and "control" shall have the
meaning given such term under Rule 405 of the Securities Act of
1933, as amended (the "Securities Act").
6
2.21. " Preferred Shares " shall
mean the shares of the Company’s Series A Preferred Stock and
Series B Preferred Stock (or Common Stock issuable upon conversion
of the Series A Preferred Stock or Series B Preferred Stock) that
the Executive now owns or hereafter acquires from the
Company.
2.22. " Put " shall mean the right of the
Executive or his/her estate to require the Company to buy Vested
Shares pursuant to Section 9.4.
2.23. " Reference Year " shall mean the year
following the year in which the Executive’s employment
termination occurs.
2.24. " Regular Severance " shall mean:
2.24.1. an amount, payable in accordance with the
Company’s customary payroll practices, for each month during
the Severance Period, equal to one-twelfth of the Executive’s
base salary in effect at the time of termination, subject to
standard deductions and withholdings; plus
2.24.2. an amount, payable monthly, equal to the monthly COBRA
payments to continue medical and dental benefits for a period
ending on the earlier of (a) the end of the last month of the
Severance Period and (b) the date on which the Executive is
covered by medical and dental insurance through his or her own
employment;
2.24.3. an amount, payable at such time as bonus payments are
due to other employees of the Company for the year in which the
termination occurs, equal to the sum of (a) one-half of the
Annual Bonus Rate for the Termination Year times Executive’s
base salary in effect at the time of termination prorated, on the
basis of a 365-day year, to reflect the number of days elapsed in
the year of Executive’s termination prior to and including
the date of termination plus (b) the Annual Bonus Rate for the
Termination Year times Executive’s base salary in effect at
the time of termination prorated, on the basis of a 365-day year,
to reflect the number of days remaining in the year of
Executive’s termination after the date of termination;
and
2.24.4. an amount, payable at such time as bonus payments are
due to other employees of the Company for the Reference Year, equal
to the Annual Bonus Rate for the Reference Year times the
Executive’s base salary in effect at the time of termination
prorated, on the basis of a 365-day year, to reflect the number of
days elapsed in the year of Executive’s termination prior to
and including the date of termination.
2.25. "Right of Repurchase" shall mean the
Company’s right to repurchase Unvested Shares pursuant to
Section 8.1.
7
2.26. " Severance Period " shall
mean 12 months plus one additional month for each quarter, up to a
maximum of 12, that the Executive has been employed by the Company
in excess of two years. For avoidance of doubt, the maximum
Severance Period is two years.
2.27. " Shares " shall mean the Common Shares and
the Preferred Shares.
2.28. " Significant Transaction " shall mean a
merger or consolidation of the Company with or into any Person, or
an acquisition of all of the business of another Person regardless
of form, if and only if, after such merger, consolidation or
acquisition, directors of the Company immediately prior to such
merger, consolidation or acquisition constitute a majority of the
directors of the surviving entity or its parent.
2.29. " Transactional Agreements " shall have the
meaning assigned in Section 1.
2.30. " Unvested Founder Shares " shall mean the
Founder Shares held by the Executive that are then subject to the
Right of Repurchase.
2.31. " Vested Shares " shall mean the Shares held
by the Executive that are not subject to the Right of
Repurchase.
2.32. " Vesting Base Date " shall mean the date(s)
set forth on Exhibit A .
3.1. Term . The Company hereby
employs the Executive, and the Executive hereby accepts employment
by the Company, upon the terms and conditions set forth in this
Agreement. The term of the Executive’s employment under the
terms and conditions of this Agreement shall continue until the
fifth anniversary of the date of this Agreement, subject to the
provisions of Section 5.
3.2. Title . The Executive shall have the title of
Senior Vice President, Development of the Company and shall also
serve in such other capacity or capacities as the Board of
Directors of the Company (the " Board ") may from
time to time prescribe. The Executive shall report to the Chief
Executive Officer of the Company.
3.3. Duties . The Executive shall do and perform
all services, acts or things necessary or advisable to manage and
conduct the business of the Company and which are normally
associated with the position of Senior Vice President, Development,
consistent with the bylaws of the Company and as required by the
Board.
3.4. Location . Unless the Parties otherwise agree
in writing, during the term of Executive’s employment under
this Agreement, the Executive shall perform the services Executive
is required to perform pursuant to this Agreement at the
Company’s
8
offices, located in Palo Alto, California;
provided, however, that the Company may from time to time require
the Executive to travel temporarily to other locations in
connection with the Company’s business.
3.5. Commitment . Unless otherwise agreed to in
advance by the Company’s Board of Directors, during the
Executive’s employment by the Company, the Executive shall
devote substantially all of Executive’s business energies,
interest, abilities and productive time to the proper and efficient
performance of Executive’s duties under this Agreement;
provided, however, the Executive may engage in other outside
business activity listed on Exhibit B hereto. If the
Executive wishes to engage in any other outside work, the Executive
agrees to notify and consult with the Board of Directors and shall
not engage in such other outside work without the prior approval of
the Board of Directors.
|
|
4.
|
Compensation of the
Executive.
|
4.1. Base Salary . The Company
shall pay the Executive a base salary at a rate of three hundred
thousand dollars ($300,000) per year for calendar year 2004,
subject to increases approved by the Board of Directors for
calendar years thereafter, less payroll deductions and all required
withholdings, payable in regular periodic payments in accordance
with Company policy. Such base salary shall be prorated for any
partial year of employment on the basis of a 365-day
year.
4.2. Bonus . In addition to Executive’s base
salary, the Executive will be entitled to receive a bonus
determined in accordance with an executive bonus plan established
by the Board of Directors. The target bonus for the Executive shall
be 40% (subject to increases approved by the Board of Directors) of
the annual base salary rate.
4.3. Employment Taxes . All of the
Executive’s compensation shall be subject to customary
withholding taxes and any other employment taxes as are commonly
required to be collected or withheld by the Company.
4.4. Benefits . The Executive shall, in accordance
with Company policy and the terms of the applicable plan documents,
be eligible to participate in benefits under any executive benefit
plan or arrangement which may be in effect from time to time and
made available to the Company’s executive or key management
employees.
4.5. Vacation . Executive shall be eligible for
paid time off and holidays in accordance with the Company’s
standard policies for executive employees.
4.6. Expenses . The Company shall reimburse
Executive for all reasonable, documented out-of-pocket business
expenses incurred on behalf of the Company in the performance of
the Executive’s duties.
9
5.1. Termination by the Company .
The Executive’s employment with the Company may be terminated
under the following conditions:
5.1.1. Death or Disability . The Executive’s
employment with the Company shall terminate effective upon the date
of the Executive’s death or Complete Disability.
5.1.2. For Cause . The Company may terminate the
Executive’s employment under this Agreement for Cause by
delivery of notice to the Executive specifying the Cause or Causes
relied upon for such termination. Any notice of termination given
pursuant to this Section 5.1.2 shall effect termination as of
the future date specified in such notice or, in the event no such
date is specified, on the last day of the month in which such
notice is delivered or deemed delivered as provided in
Section 15 below.
5.1.3. Without Cause . The Company may terminate
the Executive’s employment under this Agreement at any time
for any reason other than for "Cause" by delivery of notice of such
termination to the Executive. Any notice of termination given
pursuant to this Section 5.1.3 shall effect termination as of
the future date specified in such notice or, in the event no such
date is specified, on the last day of the month in which such
notice is delivered or deemed delivered as provided in
Section 15 below.
5.2. Termination By The Executive . The Executive
may terminate the Executive’s employment with the Company
under the following conditions:
5.2.1. For Good Reason . The Executive may
terminate the Executive’s employment under this Agreement for
Good Reason effective 30 days following delivery of notice to the
Company specifying the Good Reason relied upon by the Executive for
such termination, provide
|